MVHS adds new treatment option for enlarged prostate

UTICA, N.Y. — The Mohawk Valley Health System (MVHS) now offers Aquablation therapy for the treatment of lower urinary-tract symptoms due to benign prostatic hyperplasia (BPH).

Also known as an enlarged prostate, BPH is a non-cancerous condition where the prostate grows to be larger than normal. One in two men ages 51 to 60 have this condition, and the incidence of it increases every decade of life. Left untreated, BPH can cause significant health problems such as irreversible bladder or kidney damage, bladder stones, and incontinence. Surgical treatments can come with side effects including incontinence, erectile dysfunction, or ejaculatory dysfunction that can force patients to choose between symptom relief and those complications.

Aquablation therapy is an advanced, minimally invasive treatment that uses water delivered with robotic precision to provide symptom relief with low rates of irreversible complications.

“We are proud to be among the first in Upstate New York to offer a solution for men with BPH that provides relief without compromise,” Hanan Goldberg, chief of Upstate Urology at MVHS, said in a statement. “Aquablation therapy is the next step to furthering our commitment at MVHS to men’s health and new innovations to provide treatments and relief to our community.”

The treatment uses the AquaBeam Robotic System, which uses automated tissue resection to treat lower urinary tract symptoms due to BPH. It uses real-time, multi-dimensional imaging along with automated robotic technology and heat-free waterjet ablation technology for targeted, controlled, and immediate removal of prostate tissue. It offers predictable and reproducible outcomes independent of prostate anatomy, prostate size, or surgeon experience, MVHS said.